Veterinary Medicines

Fenoflox 100 mg/ml Solution for Injection for Cattle and Pigs

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Fenoflox 100 mg/ml Solution for Injection for Cattle and Pigs
CHANENRO 100 MG/ML SOLUTION INJECTABLE POUR BOVINS ET PORCINS
Active substance:
  • Enrofloxacin
Target species:
  • Pig
  • Cattle
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Enrofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        13
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        5
        day
      • Milk
        3
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        12
        day
      • Milk
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 20 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 15 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 12 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 10 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 5 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 250 ml No. of containers in a carton: 1 x 250 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 20 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 15 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 12 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 10 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 5 x 100 ml
  • Container material: Type I Amber Glass Container closure: Grey teflonised chlorobutyl rubber stopper with an aluminium cap. Container colour: Amber Container volume: 100 ml No. of containers in a carton: 1 x 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/2817502 5/2010
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0223/002
Concerned member states:
  • Austria
  • Belgium
  • Finland
  • France
  • Germany
  • Hungary
  • Italy
  • Luxembourg
  • Norway
  • Portugal
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download

ie-spc-vpa10987-072-002-en.pdf

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."